ASS1 and cancer: Furthermore, since CR levels reflect the contribution of multiple genes to the dysregulation of the urea cycle, CR levels may identify more cancer patients who are likely to respond to arginase-based therapies compared with the current rationale of using ASS1 expression alone, which fails to identify subsets of tumors that will be sensitive to this emerging therapy (54).